STOCKHOLDERS' EQUITY | The authorized capital stock for the Company is 51,100,000 shares, consisting of (i) 50,000,000 shares of common stock, par value $0.0001 and (ii) 1,000,000 shares of preferred stock, par value $0.0001, and (iii) 100,000 shares of class A common stock, par value $0.0001. Of the authorized shares, 24,232,895 and 24,224,924 shares of common stock were outstanding as of August 31, 2017 and May 31, 2017, respectively. No shares of preferred stock or Class A common stock were outstanding at August 31, 2017 and May 31, 2017. Stock-Based Compensation At August 31, 2017, the Company had 806,672 shares available for future grants under its stock-based compensation plans. The Company may grant restricted stock awards, restricted stock units and stock options to aid in recruiting and retaining employees, officers, directors and other consultants. In addition, the Company settles a portion of the compensation of the Chief Executive Officer in stock, which totaled $31 for the quarter ended August 31, 2017. These issuances reduce the shares available for future grants. Restricted stock The Company has 46,945 non-vested restricted stock shares with a weighted average grant date fair value of $1.96 per share outstanding at August 31, 2017. Unrecognized compensation expense associated with these shares totals $10 with a remaining amortization of 0.1 year. There were no restricted stock awards granted nor any restricted stock shares vested during the quarter ended August 31, 2017. Stock compensation expense totaling $26 was recorded in the condensed consolidated statements of operations and comprehensive income during the quarter ended August 31, 2017. Performance-based restricted stock units During the quarter ended August 31, 2017, the Company issued 281,250 performance based restricted stock units (“RSUs”) with a weighted average grant date fair value of $2.38 per share. All RSUs issued remain outstanding at August 31, 2017. Up to 100% of the RSUs issued will vest on October 20, 2018, based on the annual operating income attained during the 2018 fiscal year. Unrecognized compensation expense associated with these shares totals $669 with a remaining amortization life of 1.1 years. Stock compensation expense was not recorded in the condensed consolidated statements of operations and comprehensive income during the quarter ended August 31, 2017. Based on the Company’s financial performance for the quarter ended August 31, 2017, management did not believe the performance metrics would be met. Stock options The Company accounts for stock option-based compensation by estimating the fair value of options granted using a Black-Scholes option pricing model. The Company recognizes the expense for grants of stock options on a straight-line basis in the consolidated statements of operations and comprehensive income as operating expense based on their fair value over the requisite service period. There were no stock options issued or exercised during the quarter ended August 31, 2017. Stock options for 1,750 shares of common stock with a weighted average exercise price of $9.35 were forfeited during the quarter ended August 31, 2017. At August 31, 2017, stock options for 189,100 shares were outstanding and exercisable with a weighted average exercise price of $3.79 and a weighted average remaining useful life of 7.4 years. The intrinsic value associated with the stock options at August 31, 2017 totaled $2.50. There was no unamortized compensation associated with stock options at August 31, 2017. Dividends The following table presents details of the Company’s fiscal 2017 and 2016 dividend payments: Date declared Record date Payment date Per share April 4, 2016 June 30, 2016 July 8, 2016 $ 0.0450 August 8, 2016 September 30, 2016 October 7, 2016 $ 0.0450 October 3, 2016 December 31, 2016 January 13, 2017 $ 0.0450 January 28, 2017 March 31, 2017 April 7, 2017 $ 0.0450 April 13, 2017 June 30, 2017 July 7, 2017 $ 0.0450 August 4, 2017 September 30, 2017 (est) Oct 6, 2017 $ 0.0450 |